Healthcare

15:05

                            Novo Nordisk's European shares fell 7% after the Trump administration abandoned a proposal to cover weight loss drugs with Medicare.
                        
15:04

                            Novo Nordisk's European shares fell 7% as the Trump administration abandoned its proposal to cover weight loss drugs with Medicare
                        
                            Novo Nordisk's European shares fell 7% after the Trump administration abandoned a proposal to cover weight loss drugs with Medicare.
                        
09:49

                            The Hang Seng Index's intraday decline widened to 10%, the Hang Seng Tech Index fell 11.8%, and WuXi Biologics (02269.HK) fell more than 20%.
                        
04:20

                            Market news: The Trump administration has abandoned the health insurance plan for weight loss drugs proposed during former US President Biden's term.
                        
17:32

                            Southbound funds made a large net purchase of 28.79 billion yuan today. In terms of Hong Kong Stock Connect (Shanghai), Tracker Fund Management and Alibaba-W received net purchases of HK$5.285 billion and HK$1.921 billion respectively; Shenzhou International ranked first in net sales, with an amount of HK$12 million; in terms of Hong Kong Stock Connect (Shenzhen), Hang Seng China Enterprises and Alibaba-W received net purchases of HK$3.125 billion and HK$1.566 billion respectively; WuXi Biologics ranked first in net sales, with an amount of HK$103 million.
                        
16:10

                            Hong Kong stocks closed: Hang Seng Index closed down 1.52% Hang Seng Technology Index closed down 2.09%
                        
                            At the close of Hong Kong stocks, the Hang Seng Index closed down 1.52%, and the Hang Seng Technology Index closed down 2.09%. The Hong Kong Stock Technology ETF (159751) closed down 1.64%, and the Hang Seng Hong Kong Stock Connect ETF (159318) closed down 1.10%. WuXi Biologics, Alibaba, and JD.com fell more than 5%, while Xiaomi Group rose more than 3%.
                        
17:32

                            Southbound funds made a large net purchase of 11.717 billion yuan today. In terms of Hong Kong Stock Connect (Shanghai), Tencent Holdings and Alibaba-W received net purchases of HK$935 million and HK$828 million respectively; RoboSense ranked first in net sales, with an amount of HK$4 million; in terms of Hong Kong Stock Connect (Shenzhen), Xiaomi Group-W and Alibaba-W received net purchases of HK$1.255 billion and HK$691 million respectively; WuXi Biologics ranked first in net sales, with an amount of HK$150 million.
                        
16:50

                            WuXi AppTec: Sold 50.8 million shares of WuXi Helian, accounting for approximately 4.23% of the total share capital, with a transaction amount of approximately HK$2.178 billion
                        
                            WuXi AppTec announced that on April 1, 2025, the company continued to sell 50.8 million shares of WuXi Helian through block trading, accounting for approximately 4.23% of WuXi Helian's current total share capital, with a transaction amount of approximately HK$2.178 billion (excluding transaction fees such as handling fees), accounting for 3.43% of the company's latest audited net assets attributable to the parent company's shareholders (2024). According to preliminary calculations by the company's financial department in accordance with Chinese Accounting Standards, the investment income from the sale of WuXi Helian shares was approximately RMB 1.847 billion, accounting for more than 10% of the company's latest audited net profit attributable to the parent company's shareholders (2024), affecting the company's net profit in the first half of 2025 by approximately RMB 1.847 billion.
                        
13:32

                            The A-share CRO concept sector fluctuated downward, Hehua shares hit the limit, and Heyuan Biopharma, Baihua Pharmaceutical, Corning Life Sciences, WuXi AppTec, and Tiger Pharmaceuticals followed suit.
                        
13:30

                            CRO concept fluctuates downward and Hehua shares hit the limit down
                        
                            CRO concept stocks fluctuated downward, Hehua shares hit the limit, Heyuan Biopharma, Baihua Pharmaceutical, Corning Life Sciences, WuXi AppTec, Tiger Pharmaceuticals and others all fell.
                        
16:54

                            Huadong Medicine: The application for marketing approval of semaglutide injection has been accepted
                        
                            Huadong Medicine announced that its wholly-owned subsidiary Hangzhou Sino-US Huadong Pharmaceutical Jiangdong Co., Ltd. received the "Acceptance Notice" from the State Food and Drug Administration, and its application for marketing authorization of semaglutide injection has been accepted. The drug is a long-acting glucagon-like peptide-1 receptor agonist, mainly used to control blood sugar in patients with type 2 diabetes and weight management in obese or overweight patients. The original developer of semaglutide injection is Novo Nordisk, and it has been launched in many markets around the world. The total direct investment in the research and development of this drug is approximately 196 million yuan. The acceptance of this listing application marks an important progress in the research and development of the drug, which will help enhance the company's competitiveness in the field of endocrine therapy in the long run.
                        
09:54

                            Hong Kong-listed pharmaceutical stocks fluctuated higher, with Kanglong Chemical rising nearly 7%.
                        
                            Hong Kong-listed pharmaceutical stocks fluctuated higher, with Corning Life Sciences rising nearly 7%, followed by WuXi Biologics, CStone Pharmaceuticals, WuXi AppTec, and Tiger Pharmaceuticals.
                        
17:54

                            Eli Lilly's new lipid-lowering drug data released can reduce genetic risk factors for heart disease by 94%
                        
                            Eli Lilly and Company announced clinical data on its lipid-lowering drug lepodisiran at the American College of Cardiology meeting, showing that the highest dose of the drug reduced the level of genetic risk factors for heart disease by 94% in a mid-term trial.
                        
10:10

                            A-share innovative drug concepts hit bottom and rebounded, with Shengno Biologics hitting the daily limit, followed by Hansen Pharmaceuticals, BeiGene, Hisun Pharmaceuticals, and Baihua Pharmaceuticals.
                        
10:07

                            Innovative drug concept bottomed out and rebounded, Shengnuo Biopharma hit the daily limit
                        
                            The concept of innovative drugs hit bottom and rebounded, Shengno Biopharma hit the daily limit, followed by Hanyu Pharmaceuticals, BeiGene, Hisun Pharmaceuticals, Baihua Pharmaceuticals and others.
                        
1744009552
112763
3

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Trends

AI AI Tesla bitcoin Xiaomi Tencent Huawei Alibaba Nvidia Apple

Weekly Highlights

                                    Personal wealth shrunk by $100 billion, Musk admitted that leading DOGE cost him a heavy price
                            2025-03-31

                                    Source: SpaceX plans to build multiple Starlink ground stations in Vietnam.
                            2025-04-01

                                    Zhipu CEO: The company will assist other countries in creating artificial intelligence models.
                            2025-03-31

                                    Hong Kong stocks opened, the Hang Seng Index opened up 0.42%, and the Tech Index opened up 0.88%. Xpeng Motors (09868.HK) rose about 4%, with 33,205 vehicles delivered in March, a year-on-year increase of 268%.
                            2025-04-01

                                    Tencent Holdings (00700.HK) repurchased 996,000 shares for HK$500.9 million on April 2.
                            2025-04-02